Cargando…

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments

It has been reported that hepatitis C virus (HCV) infection is closely associated with hepatic metabolic disorders. Hepatic steatosis and insulin resistance are both relatively common in patients with chronic hepatitis C. Recent investigations suggest that HCV infection changes the expression profil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enjoji, Munechika, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakamuta, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373124/ https://www.ncbi.nlm.nih.gov/pubmed/22701799 http://dx.doi.org/10.1155/2012/264017

Ejemplares similares

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
por: Kohjima, Motoyuki, et al.
Publicado: (2007)

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake
por: Yasutake, Kenichiro, et al.
Publicado: (2012)

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A retrospective study
por: Kotoh, Kazuhiro, et al.
Publicado: (2008)

A high prevalence of extreme hyperferritinemia in acute hepatitis patients
por: Kotoh, Kazuhiro, et al.
Publicado: (2009)

Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods
por: Nakamuta, Makoto, et al.
Publicado: (2006)

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
por: Enjoji, Munechika, et al.
Publicado: (2010)

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
por: Enjoji, Munechika, et al.
Publicado: (2012)

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
por: Fujino, Tatsuya, et al.
Publicado: (2011)

Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats
por: TANAKA, MASATAKE, et al.
Publicado: (2014)

Transforming Growth Factor‐α Induces the Differentiation of Sarcomatoid Cholangiocarcinoma Cells
por: Enjoji, Munechika, et al.
Publicado: (2000)

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment
por: Hirayama, Takeshi, et al.
Publicado: (2017)

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients
por: Nakamuta, Makoto, et al.
Publicado: (2007)

The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments
por: Siphepho, Phumelele Yvonne, et al.
Publicado: (2021)

Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report
por: KUWAYAMA, MIYUKI, et al.
Publicado: (2016)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Hepatic Steatosis as a Marker of Metabolic Dysfunction
por: Fabbrini, Elisa, et al.
Publicado: (2015)

Changes in human hepatic metabolism in steatosis and cirrhosis
por: Schofield, Zoe, et al.
Publicado: (2017)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma
por: Suzuki, Hideo, et al.
Publicado: (2021)

Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents
por: Wicklow, Brandy A., et al.
Publicado: (2012)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Drazilova, Sylvia, et al.
Publicado: (2018)

Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis
por: Seidemann, Lena, et al.
Publicado: (2021)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Hepatic Steatosis Assessment as a New Strategy for the Metabolic and Nutritional Management of Duchenne Muscular Dystrophy
por: Tang, Ya-Chun, et al.
Publicado: (2022)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis
por: Sheridan, David A., et al.
Publicado: (2022)

The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients
por: El-Ghandour, Ahmed, et al.
Publicado: (2023)

Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
por: Nevola, Riccardo, et al.
Publicado: (2020)

Leptin attenuates D(2) receptor‐mediated inhibition of putative ventral tegmental area dopaminergic neurons
por: Murakami, Takami, et al.
Publicado: (2018)

Impact of Hepatic Steatosis on Resting Metabolic Rate and Metabolic Adaptation in Response to Intentional Weight Loss
por: Rachakonda, Vikrant P., et al.
Publicado: (2019)

Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus
por: Glitscher, Mirco, et al.
Publicado: (2021)

Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2021)

PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism
por: Pan, Qin, et al.
Publicado: (2017)

Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
por: Estefan, Sergio, et al.
Publicado: (2021)

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
por: Kim, Dal-Sik, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rkqha3odp7pi8bk4o402pt225k